Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT06011382 |
Other study ID # |
NKarvelas |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 20, 2022 |
Est. completion date |
June 20, 2025 |
Study information
Verified date |
August 2023 |
Source |
Grigore T. Popa University of Medicine and Pharmacy |
Contact |
Nikolaos Karvelas, PhD student |
Phone |
+40 759481645 |
Email |
karvelas93[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The aim of this randomized controlled clinical trial is to evaluate the dentoalveolar and
skeletal treatment effects of the AMDA when used for distalization of the maxillary first
molars in patients with Class II malocclusion in the permanent dentition.
Description:
The primary aim is to evaluate two different treatment groups from initiation of treatment up
until completion of maxillary molar distalization of:
- Group I: patients treated with amda®
- Group II: patients treated with buccal mini-implants
More specifically to evaluate the efficiency of the AMDA using lateral cephalograms and
digital 3D model casts of the patients under investigation at the following time points:
- point T0: baseline data - before initiation of the treatment
- point T1: immediately after distalization (8-12 months)